To prohibit the sale and use of glue traps for the trapping of rodents, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To prohibit the sale and use of glue traps for the trapping of rodents, and for other purposes., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Environment, Agriculture.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H54475BD9185E4348A16C00BE4BADCA79: 1. Short title This Act may be cited as the Glue Trap Prohibition Act of 2024.
- Section HB05D66F83C0240F4A5A4C3986F2BEA84: 2. Findings The Congress finds the following: A glue trap, also known as a glue board or sticky board, is comprised of a layer of cardboard, plastic, or wood...
- Section H3C69E0BF9EB148508C5EFB8FF091E046: 3. Prohibitions relating to glue traps Section 12(a)(1) of the Federal Insecticide, Fungicide, and Rodenticide Act (7 U.S.C. 136j(a)(1)) is amended— in...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To prohibit the sale and use of glue traps for the trapping of rodents, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Environment, Agriculture
Primary Purpose
This bill, To prohibit the sale and use of glue traps for the trapping of rodents, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Ted Lieu
D-CA | Primary Sponsor
Legislative Progress
IntroducedMr. Lieu (for himself and Mr. Schiff) introduced the following …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "federal_implementing_agencies"
- → Federal agencies assigned duties by the bill
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology